Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
About Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
During the past decade, Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
2008-04-01
2011-04-01
Completed
4,000
The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial
2008-08-01
2011-08-01
Unknown status
1,000
Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes
2008-12-01
2011-11-01
Completed
2,998
Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)
2009-06-01
2011-12-01
Unknown status
20
Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc)
2009-08-01
2011-12-01
Unknown status
20
A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing
2009-06-01
2014-04-01
Completed
385
Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients
2010-04-01
2012-08-01
Terminated
331
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie"
#1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
According to Clinical.Site data, the most researched conditions in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" are
"Acute Myeloid Leukemia" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "Lymphoblastic Lymphoma, Childhood" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Mature B-cell Non-Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
Most popular intervention types in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "Cytarabine" (2 trials), "Dexamethasone" (2 trials), "Ifosfamide" (2 trials) and "Methotrexate" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
The vast majority of trials in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie" are
5 trials for "All" genders.
Clinical Trials Status at Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie
Currently, there are NaN active trials in "Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kepler Universitätsklinikum Linz, Med. Campus III., Univ.-Klinik für Hämatologie und Internistische Onkologie, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".